Javier Queiruga‐Parada

Phase I dose-escalation single centre clinical trial to evaluate the safety of infusion of memory T cells as adoptive therapy in COVID-19 (RELEASE)

Antonio Pérez‐Martínez, Marta Mora-Rillo, Cristina Ferreras et al. · EClinicalMedicine · 2021 · 37 citations · Full text

Life Sciences, Immunology, Infectious Diseases +16

Tenofovir Disoproxil Fumarate/Emtricitabine and Baricitinib for Patients at High Risk of Severe Coronavirus Disease 2019: The PANCOVID Randomized Clinical Trial

Rocío Montejano, Fernando Calle, María Velasco et al. · Clinical Infectious Diseases · 2022 · 20 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +13

Results of phase 2 randomized multi-center study to evaluate the safety and efficacy of infusion of memory T cells as adoptive therapy in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pneumonia and/or lymphopenia (RELEASE NCT04578210)

Cristina Ferreras, Clara Hernández-Blanco, Alejandro Martín‐Quirós et al. · Cytotherapy · 2023 · 16 citations

Life Sciences, Immunology, Infectious Diseases +17

A phase I/II dose-escalation multi-center study to evaluate the safety of infusion of natural killer cells or memory T cells as adoptive therapy in coronavirus pneumonia and/or lymphopenia: RELEASE study protocol

Irene García-García, Pilar Guerra‐García, Cristina Ferreras et al. · Trials · 2021 · 13 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

Melatonin in the Prophylaxis of SARS-CoV-2 Infection in Healthcare Workers (MeCOVID): A Randomised Clinical Trial

Irene García-García, Enrique Seco-Meseguer, Pilar Ruíz-Seco et al. · Journal of Clinical Medicine · 2022 · 12 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +15